Drug or treatment
Ulixertinib clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Ulixertinib that are recruiting, in United States. By phase: Phase 1 (2), Early Phase 1 (1), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining ruxolitinib and ulixertinib for treating myelofibrosis | Phase 1/2 | Boston, Massachusetts and 8 other locations | Recruiting | Jan 14, 2025 |
| Ulixertinib treatment for histiocytic neoplasms | Phase 2 | Rochester, Minnesota and 7 other locations | Recruiting | May 13, 2024 |
| Combining ulixertinib with cetuximab and encorafenib for advanced colorectal cancer | Phase 1 | Houston, Texas | Recruiting | Aug 14, 2023 |
| Testing ulixertinib for low-grade gliomas in adults | Early Phase 1 | Houston, Texas | Recruiting | Apr 7, 2023 |
| Combining ulixertinib and palbociclib for advanced pancreatic and solid tumors | Phase 1 | Chapel Hill, North Carolina | Recruiting | Mar 5, 2018 |
All recruiting trials (5)
-
Combining ruxolitinib and ulixertinib for treating myelofibrosis
This study is testing if combining two medications, ruxolitinib and ulixertinib, can help people with myelofibrosis who haven't had enough relief from ruxolitinib alone.
-
Ulixertinib treatment for histiocytic neoplasms
This study is testing a new treatment called ulixertinib to see if it can help people with a rare type of cancer called histiocytic neoplasms.
-
Combining ulixertinib with cetuximab and encorafenib for advanced colorectal cancer
This study is testing a new combination of three drugs to see if they can safely help people with advanced colorectal cancer who haven't responded to other treatments.
-
Testing ulixertinib for low-grade gliomas in adults
This study is testing if a new drug called ulixertinib can effectively reach and treat low-grade brain tumors in adults after surgery.
-
Combining ulixertinib and palbociclib for advanced pancreatic and solid tumors
This study is testing a new combination of two drugs, ulixertinib and palbociclib, to see if they can safely help adults with advanced solid tumors, including pancreatic cancer and melanoma, who haven't responded to other treatments.
Quick answers
How many clinical trials of Ulixertinib are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Early Phase 1: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.